Author | John Puisis

John Puisis is a consultant with Spencer Stuart, an investment advisor specializing in biotech and pharmaceutical companies, based in Chicago.

Articles

Pharmaceutical Executive

BioTech's New Business Model

Coined in the early 1940s, the hybrid term "biotech" has sustained its save-the-world aura and futurist allure. During the industry's nascent years, Amgen, Genentech, and other barrier-breaking companies were mere fledgling operations with products still in the pure science phase and their only "revenue" the hope of curing some of the world's ills.